www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Companies

Pharma firm's R&D efforts bear fruit

By ZHOU WENTING in Shanghai | China Daily | Updated: 2023-03-30 10:13
Share
Share - WeChat
A visitor views exhibition boards at the exhibition area of pharmaceutical company AstraZeneca during the fifth China International Import Expo in Shanghai on Nov 7. [Photo/China Daily]

Through the upgraded AstraZeneca's Global R&D China Center, which was unveiled in Shanghai in October 2021, a rising number of biotech innovations are being promoted to contribute to global development, said a senior executive of the United Kingdom-based pharmaceutical company.

The company will continue to increase its research and development capability and expand its collaboration with the ecosystem that is developing in China, said Susan Galbraith, executive vice-president and head of oncology R&D at AstraZeneca during her trip to China last week.

"R&D efforts will address not only the cancers prevalent in Asia but those that are prevalent globally, such as breast, lung, prostate and colorectal cancers," she said.

She raised the example of Savolitinib, a drug co-developed with leading Chinese company Hutchmed. The drug achieved approval in China in 2021 and AstraZeneca is developing its global approvals for both lung and gastric cancer drugs.

Another example is that the company has recently entered into cooperation with local biotech enterprise Harbour BioMed on the development and commercialization of an innovative immune cell engager that may benefit gastric cancer patients, she said.

The company's collaborations with its Chinese partners are beginning to bear fruit. Opportunities for results derived from China are rising, especially due to the country's accelerated developing ecosystem in biopharmaceutical development, allowing the market to become an important source of innovation, said Galbraith, who was scheduled to meet with biotech enterprises and academic and medical institutions during her visit.

"We are starting to see that the medicines developed in China are parallel with the speed of global R&D. In some areas, China's innovation is potentially leading. With evolution, that will continue to happen," she said.

China's ecosystem of biotech and entrepreneurs is growing and so is its capability and experience, said Galbraith.

"A partnership with a company like AstraZeneca can help advance science and build capability. I hope we can help bring capability further in China through our partnerships," she said.

He Jing, senior vice-president and head of AstraZeneca R&D China, said that the cancer types afflicting a large number of patients in China will continue to be a focus of the company's R&D efforts.

"We'll continue to explore immunotherapy, especially regarding ones with higher prevalence in China, for example, gastric, liver and cellular cancers," she said.

Meanwhile, the company is building clinical programs at different stages, targeting gastric and liver cancers, He said.

"We forecast that AstraZeneca's R&D investment in China will triple that in 2020 by the end of this year and the R&D team will be expanded to 900," said Galbraith.

She also mentioned that artificial intelligence has been used throughout new drug discoveries and the development process.

"In the future, I can see the new generative AI technology with a large language model, like ChatGPT for example, can also be used to help speed up many different aspects of how we work," she said.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 美国黑人特大一级毛片 | 99成人免费视频 | 亚洲免费成人 | 伊人久久精品午夜 | 日本人成18在线播放 | 国产天堂 | 亚洲精品一区二区三区四 | 日韩一区在线播放 | 在线一级片 | 欧美xxxwww | 国产成人精品视频频 | 欧美一级毛级毛片 | 久章草在线视频 | www黄网站| 午夜免费福利网站 | 久久久久久久性高清毛片 | 一本色综合 | 一级成人a毛片免费播放 | 欧美大胆一级视频 | 成人国产网站 | 九九久久九九久久 | 国产伦精品一区三区视频 | 欧美性猛交xxxxx按摩国内 | 国产亚洲精品一区二区在线播放 | 精品日本亚洲一区二区三区 | 亚洲精品久久久久久久网站 | 久久久婷 | 久久久免费观成人影院 | 成人久久在线 | 亚洲一区二区三区高清 | 国产精品久久久久免费视频 | 久久99亚洲精品久久久久 | 91精品国产一区二区三区四区 | 日本免费二区三区久久 | 请看一下欧美一级毛片 | 精品午夜寂寞影院在线观看 | 成人黄色免费观看 | 国产91一区二区在线播放不卡 | 国产午夜精品理论片免费观看 | 91国内视频在线观看 | 久草网首页 |